Neurable, a Massachusetts-based neurotechnology company, has closed a $35 million Series A funding round led by Spectrum Moonshot Fund. The investment will accelerate commercialization of Neurable AI, the company's patented brain-signal processing technology that integrates brain-computer interface (BCI) capabilities into everyday consumer devices. This brings total funding to $65 million.
The company is moving advanced neurotechnology out of research labs and into daily life. Brain insights could soon be as accessible as heart-rate or sleep tracking. Neurable recently launched the MW75 Neuro LT, headphones paired with an updated app that delivers real-time cognitive insights including mental fatigue, cognitive recovery, and focus state detection. Multiple independent evaluations and peer-reviewed studies have validated these capabilities.
"Our mission is to make understanding your brain as natural and intuitive as checking your steps," said Dr. Ramses Alcaide, CEO and Co-Founder of Neurable. "With the MW75 Neuro LT and the redesigned Neurable app, people can finally see how their mind performs throughout the day. This funding allows us to scale Neurable AI into new devices and new industries, making cognitive health an accessible, daily utility for everyone."
The Series A funding will support expansion across new OEM categories and partners in lifestyle, sports, and fitness, while also deepening work in defense and safety sectors where cognitive performance and real-time brain insights are particularly valuable. Neurable plans to integrate its technology into additional form factors including earbuds and glasses, while strengthening the core platform that supports these deployments.
Gaming and e-sports represent a major focus area. Concentration, reaction time, and cognitive endurance directly impact competitive results, making this sector a natural fit for brain-tracking technology.
"Gaming is one of the most immediate and intuitive applications of Neurable AI," said Adam Molnar, Co-Founder and VP of Strategic Partnerships at Neurable. "Players are constantly pushing their cognitive limits. By integrating brain insights directly into gaming workflows and devices, we're opening a new frontier in player performance and game design."
Spectrum Moonshot Fund understands category-defining technologies and saw that Neurable achieved something unique: lab-grade brain-signal processing in an everyday device. Their support validates both Neurable's scientific foundation and the long-term commercial potential of cognitive health.
"We invested in Neurable because the team has achieved something remarkable: bringing high-quality BCI technology into an elegant consumer product powered by outstanding signal-processing algorithms," said Mauro Guebeli, Investment Manager at Spectrum Value Management. "We believe this is only the beginning and that this highly motivated team is well positioned to build a powerful platform in this emerging space."
Pace Ventures, an existing investor, participated in the round.
"We view Neurable as a leader in translating deep scientific breakthroughs into an effective, accessible, and desirable consumer product that can harness the power of the human brain for more conscious and healthier lives," said Marius Swart, Managing Partner at Pace Ventures.
Beyond consumer applications, Neurable continues strengthening its position in research and BCI-enabled product categories. The company recently partnered with iMotions, a human behavior research platform, integrating Neurable's headsets into its software suite. This partnership enables researchers and product teams to capture neural data at scale for behavioral studies and product testing.
Neurable also collaborated with MeSpace to study how adaptive workstations affect cognitive performance, demonstrating potential applications in workplace wellness and productivity optimization.
Neurable's origin traces back to a formative experience in Dr. Ramses Alcaide's life. When he was younger, his uncle, also a scientist, suffered a serious trucking accident that left him unable to walk. Alcaide watched him struggle to relearn basic movement using the limited technology available at the time. The experience left a lasting impression.
That pushed Alcaide toward neuroscience and brain-computer interfaces during his PhD work at the University of Michigan. He earned a PhD in Electrical Engineering and Neuroscience, with a thesis focused on novel brain-computer interfaces and EEG biomarkers for assessing cognitive function in children with cerebral palsy. This research laid the groundwork for what would become Neurable.
During his time there, Alcaide met Adam Molnar, who brought systems and engineering expertise and shared an interest in translating advanced neurotechnology into practical applications. The two connected around a common challenge: promising brain-computer interface research rarely worked outside controlled lab environments.
In 2015, they founded Neurable to address that gap, building non-invasive brain-computer interface technology that could operate reliably in real-world settings. While Neurable's applications have expanded over time—from accessibility into brain health and performance—the company's core motivation has remained the same: creating technology that gives people greater agency and understanding over how their brains interact with the world.
The company's platform relies on patented signal processing developed through decades of research across leading labs and institutions, enabling high-performance brain-computer interfaces without requiring invasive procedures or specialized equipment.
The brain-computer interface market is projected to exceed $52 billion globally by 2034 as demand grows for tools that monitor and optimize cognitive performance. Brain data is becoming a standard layer in how people work, play, and manage their well-being.
Neurable is positioning itself to lead this transition with tools designed to make brain understanding intuitive, ethical, and widely available. By embedding BCI capabilities into devices people already use, the company aims to accelerate adoption across multiple markets.
With fresh capital and expanding partnerships, Neurable is working to establish brain health monitoring as a practical daily habit, similar to how fitness trackers normalized heart-rate monitoring over the past decade.
